수의사 과정
Oncology
ISVPS General Practitioner Certificate (GPCert)
- 개요
- 과정
- 가격
13 Jul 2026 - 14 Jun 2027
Boost your confidence and achieve a recognised qualification
This new CPD programme is a ground-breaking course led by renowned specialists to help you develop a clinical, evidence-based approach to achieve the best outcome for your patients. Rather than following generic protocols, this programme will help you address each case individually and feel confident in the investigation and treatment of cancer in small animals.
Set yourself for success with the support of the leading CPD provider – learn how to maintain an excellent quality of life for each pet you treat and achieve a recognised qualification the General Practitioner Certificate awarded by the International School of Veterinary Postgraduate Studies (ISVPS).
이 프로그램의 주요 특징:
12 varied modules
Covering key clinical subjects in veterinary oncology
Regular assessments
Pre-module and post-module assessments encourage you to reflect on your learning and evaluate your progress
2 hands-on practical sessions
프로그램 세부 정보:
모듈 요약
- Cancer biology
- Treatment of cancer: surgery, radiation therapy and chemotherapy
- Other skin tumours and soft tissue sarcomas
- Skeletal and respiratory tumours
- Splenic tumours, haemangiosarcoma and histiocytic sarcoma
- Endocrine, neurological and ocular tumours
- Urogenital tumours and mammary tumours
- Oral and gastrointestinal tumours
- Lymphoma, leukaemia, myeloma
- Mast cell tumours
- Cytology and laboratory diagnosis of the oncology patient
- Diagnostic imaging of the oncology patient
모듈 순서는 변경될 수 있습니다
강사:
장소: Online
날짜: 13 Jul 2026 - 14 Jun 2027
GPCert in Oncology
가격 탭을 확인하세요
인증:
01 - Cancer biology
Define the hallmarks of cancer
Explain how genetic and epigenetic changes contribute to a cancer
Explain how environmental effects can contribute to a cancer
Describe specific examples of cancers in veterinary patients caused by chronic inflammation and viral infection
Compare and contrast the differences between the vasculature, immune surveillance and cellular energetics between tumour tissue and benign tissue
List the steps in the metastatic process
Describe the pathophysiology behind common paraneoplastic diseases
Describe common histopathological parameters involved in the grading of malignancies and give examples of grading systems for common cancers
Compare and contrast staging methods for round cell tumours, carcinomas and sarcomas
Give examples of different types of pain associated with cancer and give examples of how different types of pain can be managed pharmacologically
Define cancer cachexia and outline treatments to ameliorate it
02 - Treatment of cancer: surgery, radiation therapy and chemotherapy
Outline the limitations and complications possible with surgical or needle-core biopsy of solid tumours
Describe, compare and contrast different methods for assessing completeness of excision
Explain the difference between palliative and definitive radiation therapy, and give examples of cancers appropriate for each
Explain the 4 Rs of radiation therapy
Explain the difference between acute and delayed adverse effects of radiation therapy
Describe the principles and limitations of maximum tolerated dose chemotherapy
Describe the principles and limitations of metronomic chemotherapy
Describe the principles and limitations of small molecule inhibition
Give examples of the use of immunotherapy in veterinary oncology and the challenges it faces
Discuss pertinent considerations in counselling of a client whose pet is being considered for chemotherapy treatment
03 - Other skin tumours and soft tissue sarcomas
Explain a pragmatic approach to the investigation and treatment of cutaneous and subcutaneous masses in dogs
Describe the prognostic factors for soft tissue sarcomas
Describe the surgical approach to canine soft tissue sarcomas
List the options for treatment of soft tissue sarcomas where excision with appropriate margins is not possible
List the options for treatment of soft tissue sarcomas where surgical excision is incomplete
Describe appropriate chemotherapy treatments for metastatic or high-grade soft tissue sarcomas
Describe the causal factors and clinical presentation of feline injection site sarcomas
Explain how and when to investigate a cutaneous / subcutaneous mass on a cat
Describe appropriate treatment of a feline injection site sarcoma
Describe appropriate means of minimizing the risk of feline injection site sarcomas
04 - Skeletal and respiratory tumours
Describe the radiographic features of aggressive bone lesions in dogs and cats
Describe safe and pragmatic techniques of investigating aggressive bone lesions in dogs and cats
Describe the prognostic factors, staging and treatment of canine osteosarcoma
Compare and contrast the difference in behaviour and treatment between canine osteosarcoma, histiocytic sarcoma and other sarcomas of bone.
Compare and contrast the radiographic features, behaviour, treatment and prognosis between canine and feline osteosarcoma
Describe the key differential diagnoses and prognostic factors for canine and feline sinonasal tumours.
List appropriate steps in the investigation and treatment of sinonasal tumours
Describe prognostic factors and differential diagnoses for pulmonary tumours
Describe appropriate management of canine and feline pulmonary tumours
Outline the behaviour, prognosis and treatment of thymomas in cats and dogs
05 - Splenic tumours, haemangiosarcoma and histiocytic sarcoma
Explain methods of predicting the diagnosis of a splenic mass based on signalment and clinical presentation, and the accuracy of these techniques
Describe pragmatic approach to spontaneous haemoabdomen in dogs
Outline the differential diagnoses and prognosis for spontaneous haemoabdomen in cats
Explain the pathology of haemangiosarcoma, in relation to its behaviour and paraneoplastic disease
Describe prognostic factors for canine haemangiosarcoma
Describe appropriate treatments for canine haemangiosarcoma, with and without gross disease
Describe the biology, pathophysiology, epidemiology and prognostic factors for canine
Describe appropriate treatments for different presentation of histiocytic sarcoma
Outline the management of less-common splenic malignancies
06 - Endocrine, neurological and ocular tumours
Describe the pathophysiology of common tumour-related endocrinopathies of the adrenal, pituitary, thyroid, parathyroid glands and beta cells of the pancreas
Choose appropriate diagnostic tests for the diagnosis of the above endocrinopathies
Describe appropriate management of the above endocrinopathies
Outline definitive treatment for the above tumour-related endocrinopathies
Describe the clinical presentation, pathologies, and imaging findings in different neurological tumours
List the challenges in the diagnosis of neurological tumours
Describe the treatment options for neurological tumours and the factors which influence response to treatment
Outline important benign and malignant ocular tumours
Describe treatment options and prognosis for ocular tumours
07 - Urogenital tumours and mammary tumours
Describe important risk factors for the developing of a canine transitional cell carcinoma (TCC)
Describe means of diagnosis of a canine TCC (and the associated limitations)
Describe the behaviour and prognosis for canine TCCs
Describe appropriate treatments for canine TCCs
Explain the differences between canine and feline TCCs
Explain important causal factors in the development of a canine prostate tumour
Outline the biology, treatment and prognosis of the transmissible venereal tumour
Describe the prognostic factors for canine mammary tumours and outline the strongest prognostic factors
Describe the prognosis for feline mammary tumours and outline the strongest prognostic factors
Explain the evidence base for the medical treatment of canine and feline mammary tumours
08 - Oral and gastrointestinal tumours
Outline the important differential diagnoses for oral tumours in dogs and in cats
Describe an appropriate and pragmatic investigation for an oral mass
Describe treatment options and treatment options for common oral tumours in dogs and cats
Outline the important differential diagnoses for gastrointestinal and hepatobiliary tumours in dogs and in cats
Describe an appropriate and pragmatic investigation for a gastrointestinal or hepatobiliary tumour
Describe treatment options and treatment options for common gastrointestinal or hepatobiliary tumours in dogs and cats
Describe the epidemiology, clinical presentation and investigation of anal gland and perianal tumours in dogs
List important prognostic factors for anal gland tumours in dogs
Describe treatment options for both advanced and early anal gland tumours in dogs
09 - Lymphoma, leukaemia, myeloma
Compare and contrast the presentation of lymphoma in cats and dogs
Describe the means of diagnosis of lymphoma
Compare and contrast the utility of diagnostic tests to confirm or subtype lymphoma between dogs and cats
Explain the value of the information gained from staging a case of lymphoma
Describe important prognostic factors for canine and feline lymphoma
Describe appropriate treatments and prognoses for different types of canine lymphoma
Describe appropriate treatment for different presentations of feline lymphoma
Discuss the evidence base for the treatment of canine indolent lymphomas
Describe prognostic factors and treatment for chronic and acute lymphoid leukaemias in dogs and cats
Describe the presentation, diagnosis, and treatment for multiple myeloma in dogs and cats
10 - Mast cell tumours
List important prognostic factors for canine mast cell tumours, from history, physical examination and histopathology
Discuss the relative independence of one prognostic factor versus another, and outline the strongest indicators of prognosis
Explain how to use immunohistochemical labelling appropriately
Describe practical methods of staging mast cell tumours depending on their location on the body
Describe appropriate use of surgical treatment for a mast cell tumour
Describe options for treatment of an incomplete surgical excision
Explain when to use chemotherapy for mast cell tumours
Explain when to use tyrosine kinase inhibitors for mast cell tumours
Describe appropriate circumstances for the use of intralesional tigilanol tiglate.
Explain prognostic factors and outline treatment for feline cutaneous, intestinal and visceral mast cell tumours
11 - Cytology and laboratory diagnosis of the oncology patient
Explain how to identify whether a cytology sample is of adequate diagnostic quality
Describe cellular features of malignancy in the context of the cells in question
Be able to identify the cytological appearance of common benign and malignant skin tumours
Be able to identify mast cell tumours cytologically and comment on their degree of cellular differentiation
Explain the criteria for classifying a lymph node cytology smear as “lymphoma” versus “reactive hyperplasia”
Describe the use of different fine needle aspiration techniques to obtain diagnostic samples from different tumours
Explain the criteria used for the cytological diagnosis of a sarcoma and comment on features which may differentiate the type of sarcoma
Explain the cytological features of common carcinomas
Explain how flow cytometry works and why it is of value in the diagnosis of lymphoid malignancies
Describe examples of different PCR-based tests available for diagnosis of canine cancers and comment on the limitations of these tests
12 - Diagnostic imaging of the oncology patient
Describe how to take high quality radiographs of the thorax, limbs and oral cavity in the diagnosis and staging of cancer
Explain the benefits given by computed tomography over conventional radiography in the diagnosis and staging of cancer
Describe what sentinel lymph node mapping is, and why it is beneficial
Compare and contrast the use abdominal ultrasonography to abdominal computed tomography in the staging of cancer
Compare and contrast the needs of staging solid tumours from round cell tumours
Compare and contrast different techniques for identifying cancer infiltration in liver and spleen
Give examples of risks or complications from the use of image-guided fine needle aspiration or biopsy
Describe optimal combinations of imaging modalities for the staging of different cancers
Describe the basics of interpreting MR images in the diagnosis of CNS neoplasia
Outline the benefit of techniques for example PET-CT over conventional contrast CT scanning
장소: Online
날짜: 13 Jul 2026 - 14 Jun 2027
GPCert in Oncology
가격 탭을 확인하세요
인증:
가격 청구
Oncology 정규 가격
| 결제 옵션 | 첫 번째 결제 | 두 번째 결제(들) | 총 결제액 |
|---|---|---|---|
| Payment in Cash | ₩ 12272727.00 | - | ₩ 12272727.00 |
| Payment in Credit Card | ₩ 13500000.00 | - | ₩ 13500000.00 |
장소: Online
날짜: 13 Jul 2026 - 14 Jun 2027
GPCert in Oncology
가격 탭을 확인하세요

